Cerebral, a startup hoping to close a healthcare gap by providing online consultations and prescriptions for mental health issues, is betting users are open to ordering medicine for anxiety, depression and insomnia through the mail.
Co-Founder and CEO Kyle Robertson told Cheddar the company connects users with a doctor via web video who is authorized to write a prescription. Later, the patient will be matched with a care manager for ongoing consultations. Cerebral, which launched last week, sends medicine to users in “discreet,” branded packaging, he said.
The company hopes to make treatments more widely available to individuals for $92 per month, which pays for a video consultation with a physician, medication via mail, and monthly check-ins with a care manager.
Those care managers act as facilitators for medication management, Robertson said. “They help flag if medication or dosage adjustments are needed and work very closely with that prescribing provider.”
Care managers provide “psycho-social support,” he said. They call users monthly and help provide services outside of medication to supplement treatment, such as meditation, mindfulness and exercise, he said. “It’s comprehensive treatment.”
Robertson co-founded the company with Ho Anh, who used to be a doctor for Hims, the startup creating products for men’s sexual health, hair loss and skin care.
The company takes liability seriously, says Robertson, as “we are treating clients’ mental health and that’s an incredibly important thing,” but “in terms of liability there is a prescriber-client relationship, so, ultimately, that is what it comes down to.”
He said the company does not provide medications like Benzodiazepines or stimulants that may be addictive and instead focuses on “non addictive” medications like beta-blockers, SSRIs and SNRIs.
“The model we built is really catered toward making sure we are being really responsible for the clients we are taking on,” he said.
Shan Aggarwal, VP of Corporate and Business Development at Coinbase, discusses the company's acquisitio of Deribit as it heads into the S&P 500. Watch!
American businesses that rely on Chinese goods are reacting with muted relief after the U.S. and China agreed to pause their exorbitant tariffs on each other’s products for 90 days. Many companies delayed or canceled orders after President Donald Trump last month put a 145% tariff on items made in China. Importers still face relatively high tariffs, however, as well as uncertainty over what will happen in the coming weeks and months. The temporary truce was announced as retailers and their suppliers are looking to finalize their plans and orders for the holiday shopping season. They’re concerned a mad scramble to get goods onto ships will lead to bottlenecks and increased shipping costs.
Shopping expert Trae Bodge discusses how talks between the U.S. and China is good news for now, but uncertainty remains for back-to-school and the holidays.
Jake Traylor, White House reporter at Politico, joins Cheddar to discuss how Trump is aiming to lower drug prices and how it differs from Biden's approach.
DJ X, alongside Molly Holder, Senior Director of Product Personalization, takes us inside Spotify's A.I. DJ and how it's the best new way to listen to music.
Sheryl Palmer, CEO of Taylor Morrison, talks tariff uncertainty, being a female leader in a male dominated industry and what homebuyers need to know. Watch!
